| Revision of Previously Issued Quarterly Information |
Revision of Previously Issued Quarterly Information (in thousands, except per share data) Refer to Note 17, Revision of Previously Issued Quarterly Information, of the Notes to Consolidated Financial Statements in its Annual Report on Form 10-K for the year ended December 31, 2025 for detailed information relating to the revisions made to our prior period information.
The following tables present the effect of the revision adjustments on the previously reported unaudited condensed consolidated statement of operations and comprehensive income (loss) and unaudited condensed consolidated statement of cash flows for the three and nine months ended September 30, 2025. | | | | | | | | | | | | | | | | | | | Three months ended September 30, 2025 | | As Reported | | Adjustments | | As Revised | | Revenue | | | | | | | Software platform | $ | 30,459 | | | $ | (97) | | | $ | 30,362 | | | Professional services | 2,401 | | | (68) | | | 2,333 | | | | | | | | | Total revenue | 32,860 | | | (165) | | | 32,695 | | | Cost of revenue | | | | | | | Software platform | 6,624 | | | 13 | | | 6,637 | | | Professional services | 1,780 | | | — | | | 1,780 | | | | | | | | | Total cost of revenue | 8,404 | | | 13 | | | 8,417 | | | Gross profit | 24,456 | | | (178) | | | 24,278 | | | Operating expenses: | | | | | | | Research and development | 8,522 | | | 183 | | | 8,705 | | | Sales and marketing | 7,873 | | | — | | | 7,873 | | | General and administrative | 12,879 | | | 75 | | | 12,954 | | | | | | | | | | | | | | | Restructuring | 93 | | | — | | | 93 | | | Total operating expenses | 29,367 | | | 258 | | | 29,625 | | | Loss from operations | (4,911) | | | (436) | | | (5,347) | | | | | | | | | Other income (expense), net | 17,348 | | | — | | | 17,348 | | | Income before income taxes | 12,437 | | | (436) | | | 12,001 | | | Income tax expense | (27) | | | — | | | (27) | | | Income from continuing operations | 12,410 | | | (436) | | | 11,974 | | | Income from discontinued operations (Note 15) | 122 | | | — | | | 122 | | | Net income | 12,532 | | | (436) | | | 12,096 | | | Less: Net income attributable to noncontrolling interest included in discontinued operations | — | | | — | | | — | | | Net income attributable to Blend Labs, Inc. | 12,532 | | | (436) | | | 12,096 | | | Less: Accretion of redeemable noncontrolling interest to redemption value from discontinued operations | — | | | — | | | — | | | Less: Accretion of Series A redeemable convertible preferred stock to redemption value | (4,558) | | | — | | | (4,558) | | | Net income attributable to Blend Labs, Inc. common stockholders | $ | 7,974 | | | $ | (436) | | | $ | 7,538 | | | | | | | | | Net income per share attributable to Blend Labs, Inc. common stockholders - basic and diluted: | | | | | | | Basic | | | | | | | Continuing operations | $ | 0.03 | | | $ | (0.01) | | | $ | 0.02 | | | Discontinued operations | $ | — | | | $ | — | | | $ | — | | | Net income per share attributable to Blend Labs, Inc. common stockholders | $ | 0.03 | | | $ | (0.01) | | | $ | 0.02 | | | Diluted | | | | | | | Continuing operations | $ | 0.02 | | | $ | — | | | $ | 0.02 | | | Discontinued operations | $ | — | | | $ | — | | | $ | — | | | Net income per share attributable to Blend Labs, Inc. common stockholders | $ | 0.02 | | | $ | — | | | $ | 0.02 | | | Weighted average shares used in calculating net income per share: | | | | | | | Basic | 259,631 | | | — | | | 259,631 | | | Diluted | 268,719 | | | — | | | 268,719 | | | Comprehensive income: | | | | | | | Net income | $ | 12,532 | | | $ | (436) | | | $ | 12,096 | | | Unrealized loss on marketable securities | (62) | | | — | | | (62) | | | Foreign currency translation gain | 103 | | | — | | | 103 | | | Comprehensive income | 12,573 | | | (436) | | | 12,137 | | | Less: Comprehensive loss attributable to noncontrolling interest | — | | | — | | | — | | | Comprehensive income attributable to Blend Labs, Inc. | $ | 12,573 | | | $ | (436) | | | $ | 12,137 | |
| | | | | | | | | | | | | | | | | | | Nine months ended September 30, 2025 | | As Reported | | Adjustments | | As Revised | | Revenue | | | | | | | Software platform | $ | 84,110 | | | $ | 19 | | | $ | 84,129 | | | Professional services | 7,043 | | | (3) | | | 7,040 | | | | | | | | | Total revenue | 91,153 | | | 16 | | | 91,169 | | | Cost of revenue | | | | | | | Software platform | 18,993 | | | 101 | | | 19,094 | | | Professional services | 5,440 | | | — | | | 5,440 | | | | | | | | | Total cost of revenue | 24,433 | | | 101 | | | 24,534 | | | Gross profit | 66,720 | | | (85) | | | 66,635 | | | Operating expenses: | | | | | | | Research and development | 23,375 | | | 659 | | | 24,034 | | | Sales and marketing | 22,010 | | | — | | | 22,010 | | | General and administrative | 37,723 | | | 181 | | | 37,904 | | | | | | | | | | | | | | | Restructuring | 840 | | | — | | | 840 | | | Total operating expenses | 83,948 | | | 840 | | | 84,788 | | | Loss from operations | (17,228) | | | (925) | | | (18,153) | | | | | | | | | Other income (expense), net | 19,480 | | | — | | | 19,480 | | | Income before income taxes | 2,252 | | | (925) | | | 1,327 | | | Income tax expense | (98) | | | — | | | (98) | | | Income from continuing operations | 2,154 | | | (925) | | | 1,229 | | | Loss from discontinued operations (Note 15) | (5,679) | | | — | | | (5,679) | | | Net loss | (3,525) | | | (925) | | | (4,450) | | | Less: Net loss attributable to noncontrolling interest included in discontinued operations | 182 | | | — | | | 182 | | | Net loss attributable to Blend Labs, Inc. | (3,343) | | | (925) | | | (4,268) | | | Less: Accretion of redeemable noncontrolling interest to redemption value from discontinued operations | (1,254) | | | — | | | (1,254) | | | Less: Accretion of Series A redeemable convertible preferred stock to redemption value | (13,136) | | | — | | | (13,136) | | | Net loss attributable to Blend Labs, Inc. common stockholders | $ | (17,733) | | | $ | (925) | | | $ | (18,658) | | | | | | | | | Net loss per share attributable to Blend Labs, Inc. common stockholders - basic and diluted: | | | | | | | Basic: | | | | | | | Continuing operations | $ | (0.04) | | | $ | — | | | $ | (0.04) | | | Discontinued operations | $ | (0.03) | | | $ | — | | | $ | (0.03) | | | Weighted average shares used in calculating net loss per share: | | | | | | | Basic and diluted | 259,228 | | | — | | | 259,228 | | | | | | | | | Comprehensive loss: | | | | | | | Net loss | $ | (3,525) | | | $ | (925) | | | $ | (4,450) | | | Unrealized loss on marketable securities | (100) | | | — | | | (100) | | | Foreign currency translation gain | 53 | | | — | | | 53 | | | Comprehensive loss | (3,572) | | | (925) | | | (4,497) | | | Less: Comprehensive loss attributable to noncontrolling interest | 182 | | | — | | | 182 | | | Comprehensive loss attributable to Blend Labs, Inc. | $ | (3,390) | | | $ | (925) | | | $ | (4,315) | |
| | | | | | | | | | | | | | | | | | | Nine months ended September 30, 2025 | | As Reported | | Adjustments | | As Revised | | Operating activities | | | | | | | Net loss | $ | (3,525) | | | $ | (925) | | | $ | (4,450) | | | Net income from continuing operations | 2,154 | | | (925) | | | 1,229 | | | | | | | | | Adjustments to reconcile net loss to net cash used in operating activities: | | | | | | | Stock-based compensation | 21,376 | | | 101 | | | 21,477 | | | | | | | | | Changes in operating assets and liabilities: | | | | | | | Trade and other receivables | 2,345 | | | (120) | | | 2,225 | | | Prepaid expenses and other assets, current and non-current | (4,709) | | | 418 | | | (4,291) | | | Deferred revenue | 5,313 | | | (119) | | | 5,194 | | | Other liabilities, current and non-current | 1,686 | | | 87 | | | 1,773 | | | Net cash provided by operating activities - continuing operations | 12,060 | | | (558) | | | 11,502 | | | Net cash provided by operating activities | 10,532 | | | (558) | | | 9,974 | | | | | | | | | Additions to property, equipment and internal-use software development costs | (10,592) | | | 558 | | | (10,034) | | | Net cash provided by investing activities - continuing operations | 19,972 | | | 558 | | | 20,530 | | | Net cash provided by investing activities | 19,790 | | | 558 | | | 20,348 | |
The impact of the revisions on the Condensed Consolidated Statements of Redeemable Noncontrolling Interest, Series A Redeemable Convertible Preferred Stock, and Stockholders' Equity was solely within net (loss) income for errors impacting accumulated deficit as presented above.
|